0 projects

FRIMED2-FRIPRO forskerprosjekt, medisin og helse

Development of nanoparticle drug carriers against tuberculosis in zebrafish via control of the vasculature.

Vår gruppe har fokusert på å utvikle nanopartikler for medisin administrering mot tuberkulose og kreft, på veien mot dette målet introduserte vi i 2010 den transparente sebrafisk embryoet som en modell organisme i nanopartikkel (NP) feltet. Per nå er standard praksis å karakterisere NP in vitro o...

Awarded: NOK 9.0 mill.

Project Period: 2018-2022

Location: Ukjent Fylke

BEDREHELSE-Bedre helse og livskvalitet

Drug targeting for improved treatment of multi drug resistant tuberculosis.

Tuberkulose, forårsaket av Mycobacterium tuberculosis, er fortsatt den mest alvorlige bakterielle sykdommen hos mennesker. For inntil omtrent 10 år siden har den samme miksturen av fire antibiotika blitt benyttet for å behandle tuberkulose (TB) i over 50 år. Denne medisin kombinasjon virker og ha...

Awarded: NOK 8.0 mill.

Project Period: 2018-2021

Location: Ukjent Fylke

BIOTEK2021-Bioteknologi for verdiskaping

EMBL in Norway awareness meeting

Norway is financially supporting three different International organizations, the EMBL, EMBO and the Human Frontier Science Program (HFSP). All three organizations support Norwegian scientists to go abroad to work to top foreign research labs. However, it is also a fact that relatively few Norweg...

Awarded: NOK 67,871

Project Period: 2017-2018

Location: Ukjent Fylke

FRIMEDBIO-Fri prosj.st. med.,helse,biol

Development of nanoparticle based therapies against tuberculosis in the zebrafish model.

Mycobacterium tuberculosis (M.tb), the cause of tuberculosis (TB) infects one-third of the world population, one person per second, and kills about 2 million people per year. The only effective therapy, using antibiotics, is being challenged by increasing antibiotic resistance. It has been shown...

Awarded: NOK 9.2 mill.

Project Period: 2012-2016

Location: Ukjent Fylke

GLOBHELS-Global helse

Development of biodegradable nanobeads as vaccines against tuberculosis.

Tuberculosis (TB), which is caused by infection with the bacterium Mycobacterium tuberculosis (M.tb), is a major burden globally and causes more than 1,3 million deaths every year. The only available vaccine against TB, the live vaccine Bacille Calmette Guerin (BCG), is however largely ineffectiv...

Awarded: NOK 3.7 mill.

Project Period: 2012-2017

Location: Ukjent Fylke